It is a pharma private limited company based in Ambernath, Maharashtra, India, established in 2021.
2021 | Ambernath, Maharashtra, India | ActiveArlckon Biotech Private Limited, a active private limited company, was established on 12 February 2021 in Ambernath, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24233MH2021PTC355143. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.20 M and a paid-up capital of ₹1.20 M.
Its leadership includes Ravindra Dhondu Chopade (Director), Manisha Ravindra Chopade (Director), Nayana Lalit Chopade (Director). It holds ₹4.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Nirankar Apartment, Basement, Plot No 47, Hill Road, Ambernath, Ambernath, Maharashtra, 421501.
U24233MH2021PTC355143
355143
12 February 2021
₹1.20 M
₹1.20 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Arlckon Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Dhondu Chopade | Director | 12 Feb 2021 | Current |
| Manisha Ravindra Chopade | Director | 12 Feb 2021 | Current |
| Nayana Lalit Chopade | Director | 12 Feb 2021 | Current |
| Hemangini Arun Chopade | Director | 12 Feb 2021 | Current |
| Arun Dhondu Chopade | Director | 12 Feb 2021 | Current |
| Lalit Dhondu Chopade | Director | 12 Feb 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Arlckon Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 37.66% increase in profit. The company's net worth observed a substantial decline by a decrease of 12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Arlckon Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹45,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2024 | Others | ₹1.50 Cr | Open |
| 20 Feb 2023 | Others | ₹3.00 Cr | Open |
Explore comprehensive loan charge details -
Arlckon Biotech has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Arlckon Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arlckon Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Arlckon Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Arlckon Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 15.00 M with Charge ID 100863770 was registered on 04 Jan 2024. was completed.
The activity A charge with Others amounted to Rs. 30.00 M with Charge ID 100684415 was registered on 20 Feb 2023. was completed.
Ravindra Dhondu Chopade was appointed as a Director was appointed as a Director on 12 Feb 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
Progress on Manisha Ravindra Chopade was appointed as a Director was appointed as a Director on 12 Feb 2021 & has been associated with this company since 4 years 10 months . was documented.
The CIN of Arlckon Biotech Private Limited is U24233MH2021PTC355143.
Arlckon Biotech Private Limited is headquartered at Nirankar Apartment, Basement, Plot No 47, Hill Road, Ambernath, Ambernath, Maharashtra, 421501.
Arlckon Biotech Private Limited was incorporated on 12 February 2021.
The current directors of Arlckon Biotech Private Limited are
The primary industry of Arlckon Biotech Private Limited is Pharma.
Arlckon Biotech Private Limited is unlisted.
The authorized capital of Arlckon Biotech Private Limited is ₹1.20 M, and the paid-up capital is ₹1.20 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX